142 related articles for article (PubMed ID: 32040530)
41. COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: a nationwide study in Spain.
Baré M; Montón C; Mora L; Redondo M; Pont M; Escobar A; Sarasqueta C; Fernández de Larrea N; Briones E; Quintana JM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1233-1241. PubMed ID: 28461746
[TBL] [Abstract][Full Text] [Related]
42. Effects of screening and universal healthcare on long-term colorectal cancer mortality.
Lee YC; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Chuang SL; Hsu WF; Chiang TH; Chiu HM; Wu MS; Chen HH
Int J Epidemiol; 2019 Apr; 48(2):538-548. PubMed ID: 30184208
[TBL] [Abstract][Full Text] [Related]
43. Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky.
Gan T; Sinner HF; Walling SC; Chen Q; Huang B; Tucker TC; Patel JA; Evers BM; Bhakta AS
J Am Coll Surg; 2019 Apr; 228(4):342-353.e1. PubMed ID: 30802505
[TBL] [Abstract][Full Text] [Related]
44. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
[TBL] [Abstract][Full Text] [Related]
45. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.
Schneider EB; Hyder O; Brooke BS; Efron J; Cameron JL; Edil BH; Schulick RD; Choti MA; Wolfgang CL; Pawlik TM
J Am Coll Surg; 2012 Apr; 214(4):390-8; discussion 398-9. PubMed ID: 22289517
[TBL] [Abstract][Full Text] [Related]
46. Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017).
Darbà J; Marsà A
J Med Econ; 2020 Dec; 23(12):1623-1629. PubMed ID: 33000981
[TBL] [Abstract][Full Text] [Related]
47. Type 2 Diabetes and Hemorrhagic Stroke: A Population-Based Study in Spain from 2003 to 2012.
Muñoz-Rivas N; Méndez-Bailón M; Hernández-Barrera V; de Miguel-Yanes JM; Jimenez-Garcia R; Esteban-Hernández J; Lopez-de-Andrés A
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1431-43. PubMed ID: 27017281
[TBL] [Abstract][Full Text] [Related]
48. Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).
Binefa G; Garcia M; Milà N; Fernández E; Rodríguez-Moranta F; Gonzalo N; Benito L; Clopés A; Guardiola J; Moreno V
Sci Rep; 2016 Jan; 6():19532. PubMed ID: 26787510
[TBL] [Abstract][Full Text] [Related]
49. Impact of bowel cancer screening on the management of colorectal cancer.
Hwang MJ; Evans T; Lawrence G; Karandikar S
Colorectal Dis; 2014 Jun; 16(6):450-8. PubMed ID: 24617851
[TBL] [Abstract][Full Text] [Related]
50. Clostridium difficile-related hospitalizations and risk factors for in-hospital mortality in Spain between 2001 and 2015.
Esteban-Vasallo MD; de Miguel-Díez J; López-de-Andrés A; Hernández-Barrera V; Jiménez-García R
J Hosp Infect; 2019 Jun; 102(2):148-156. PubMed ID: 30240814
[TBL] [Abstract][Full Text] [Related]
51. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
[TBL] [Abstract][Full Text] [Related]
52. Short-term postoperative outcomes of colorectal cancer among patients with chronic liver disease: a national population-based study.
Lee KC; Chung KC; Chen HH; Cheng KC; Wu KL; Lu CC
BMJ Open; 2018 Jul; 8(7):e020511. PubMed ID: 30018094
[TBL] [Abstract][Full Text] [Related]
53. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
[TBL] [Abstract][Full Text] [Related]
54. Age-period-cohort modeling of colorectal cancer incidence and mortality in Spain.
López-Abente G; Pollán M; Vergara A; Moreno C; Moreo P; Ardanaz E; Aragonés N
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):999-1005. PubMed ID: 9419394
[TBL] [Abstract][Full Text] [Related]
55. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.
Innos K; Reima H; Baburin A; Paapsi K; Aareleid T; Soplepmann J
Cancer Epidemiol; 2018 Feb; 52():112-119. PubMed ID: 29294434
[TBL] [Abstract][Full Text] [Related]
56. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
57. Study of colorectal mortality in the Andalusian population.
Cayuela A; Rodríguez-Domínguez S; Garzón-Benavides M; Pizarro-Moreno A; Giráldez-Gallego A; Cordero-Fernández C
Rev Esp Enferm Dig; 2011 Jun; 103(6):289-93. PubMed ID: 21736394
[TBL] [Abstract][Full Text] [Related]
58. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
59. [Screening for colorectal cancer].
Caicoya M
Rev Clin Esp; 2000 Mar; 200(3):143-50. PubMed ID: 10804760
[No Abstract] [Full Text] [Related]
60. Colorectal cancer screening: a global overview of existing programmes.
Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
